UniQure NV - Company Profile
Powered by 
All the sales intelligence you need on UniQure NV in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how UniQure NV fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with UniQure NV.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
View up-to-date information on UniQure NV’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.
Number of Deals
Deal Value ($M)
Latest Deals
| Announced Date | Headline | Deal Type | Acquirers/Investors/Surviving Entity | Issuer/Partner/Target |
|---|---|---|---|---|
| 15 May 2023 | UniQure to Sell Royalty Interest in HEMGENIX to HealthCare Royalty and Sagard Healthcare for Approximately USD500 Million | Asset Transaction |
Sagard Healthcare Royalty Partners LP
Healthcare Royalty Management LLC
|
UniQure NV |
| 31 Jan 2023 | UniQure Enters into Licensing Agreement with Apic Bio | Licensing Agreement |
UniQure NV
|
Apic Bio Inc
|
| 22 Jun 2021 | uniQure Acquires Corlieve Therapeutics | Acquisition |
UniQure NV
|
Corlieve Therapeutics SAS
|
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
Contact the team or request a demo to find out how our data can drive your business forward
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer